Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on September 5, 2007
J Am Soc Nephrol 18: 2619-2621, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2007070750

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007070750v1
18/10/2619    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neilson, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neilson, E. G.
Related Collections
Right arrowRelated Article

Editorials

The Fructose Nation

Eric G. Neilson

Departments of Medicine and Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee

Correspondence: Dr. Eric G. Neilson, Department of Medicine, D-3100 Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232-2358. Phone: 615-322-3146; Fax: 615-343-9391; E-mail: eric.neilson{at}vanderbilt.edu


    Introduction
 Top
 Introduction
 Disclosures
 References
 
There is growing miasma in our national correspondence over the increasing heft and metabolic dysfunction of everyday Americans. The origin of this mounting poundage has many parents, not the least of which is our appetite for nutritive (read caloric) sweeteners in processed foods and beverages. The culprit derivatives taking most heat today are various formulations of added fructose. Bray et al.1 drew attention to the association of obesity with increasing fructose consumption in a landmark paper several years ago.

Fructose is everywhere because it is highly soluble in water, more so than glucose,2 makes bread crusts browner, cookies softer, and everything sweeter. The vast majority of sweeteners are nutritive, although nonnutritive sweeteners like acesulfame and sucralose (chlorinated sucrose) are increasingly in use. The recent shortage of sucralose suggests some retreat from fructose may already be under way. Even so, concern remains that unfettered consumption of fructose is contributing to rampant obesity, metabolic syndrome, and insulin-resistant diabetes.3 It seems we have morphed insidiously into a fructose nation.

It did not start out like this. For eons, humans sweetened their food with cane or beet sugar containing sucrose. Sucrose is metabolized into dextrose and fructose by disaccharidases in the gut and is the only sweetener allowed to label as commercial sugar. By the mid-19th century, however, the use of cornstarch as a laundry stiffener ushered in a new era for agrocorn.4 Chemists figured out how to make dextrose and anhydrous sugar from cornstarch after the Civil War, and the marketplace for corn-based sweeteners became a nascent industry. Corn syrups came next. Syrup manufactured from the dregs of corn germ led to the development of commercial dextrose, which quickly became an economical competitor of natural sucrose by the early 1900s, but that is not the end. With better corn syrup technology, chemists were eventually able to isomerize dextrose into fructose, producing a commercially successful derivative known as high-fructose corn syrup.

Fructose is sweeter than sucrose,1 and high-fructose corn syrup became a main staple of the sweetener industry beginning in 1967.5 How much fructose do we eat today? A lot. Americans increased their overall consumption of nutritive sweeteners by 41% between 1959 and 1997, to an amount nearly 10 yr ago totaling 70 kg per capita per year.6 The addition of high-fructose corn syrup to the national diet during a comparable interval7 increased exposure to fructose in high-fructose corn syrup from near zero to 29 kg per capita per year3 and a few years ago represented a large fraction of our current appetite for nutritive sweeteners.1,6 In past decades, even back to Osler, fructose was also touted as a preferred sugar substitute for individuals with diabetes because its metabolism lowers blood glucose and insulin responses.8 Now this notion seems quaint and probably ill-advised.9

If sucrose has been around for centuries and is partly metabolized to fructose, why only now do we censure fructose in the epidemic of obesity10 and metabolic syndrome?3 Opinion varies. Many foods need sweetening or no one will buy or make them. Sucrose consumption a few decades ago was largely influenced by whoever did meal preparation at home.6 Today we snack more frequently and super-size what we consume, and with reliance on vending machines and fast foods for quick calories, nimble commercial interests now influence our quantity of fructose per serving. This transition has been facilitated by perverse incentives in congressional farm bills that encouraged commodity farmers to grow more corn in the past 25 yr.11 Although entrenched supply-chain economics are hard to repurpose, much of our current corn production may have alternative use in new ethanol-based fuels.

So what is the problem with fructose? Fructose is metabolized differently than glucose. Unlike glucose, which is stored as glycogen, fructose is absorbed by the gut and converted into triglycerides by the liver.12 Fructose also elevates uric acid levels through effects on an ADP-IMP pathway in hepatocytes.13 The resulting dyslipidemia and hyperuricemia facilitate insulin resistance,14 aggravate hypertension,13 and accelerate endothelial dysfunction.15 Attenuation of nitric oxide levels is an important pathogenic mechanism as a final common pathway to poor blood flow.3,16 What we end up with is a familiar caloric additive provoking a new spate of metabolic dysfunction.3

Johnson and colleagues17 have been studying this problem in rats using diets rich in fructose that produce a metabolic syndrome with glomerular hypertension. In this issue of JASN, their group moves the story a step further by showing that exposure to thiazide diuretics in fructose-consuming rats makes metabolic syndrome worse.18 It is interesting that these rats are not obese, perhaps because the study period was too short, or, as recently observed, obesity may not be the only driver of metabolic syndrome.19

Thiazide diuretics have long been linked with glucose intolerance in humans.20,21 An elevated blood glucose in this setting is largely attributable to hypokalemia that renders glucose uptake less effective. Thiazides, which are a traditional mainstay for treating hypertension in populations with metabolic syndrome and diabetes, also raise blood levels of uric acid.22 Proper attention to potassium replacement and the lowering of serum uric acid with allopurinol in rats on high-fructose diets consuming thiazides ameliorate the aggravating circumstances of metabolic syndrome.18

Where do we go from here? It is important not to reach conclusions too quickly. Some think a commercial conversion to nonnutritive sweeteners in processed foods and beverages is the answer to the fructose problem. Nonnutritive sweeteners are quite potent; sucralose, for example, is 600 times sweeter than sucrose but has a metallic aftertaste that needs abatement.23 Mixing in inulin can improve palatability,24 and nephrologists will enjoy that piece of trivia. Although a change to nonnutritive sweeteners would reduce exposure to fructose, there is a curve ball and the irony is this: Consumables laced with nonnutritive sweeteners seemingly produce less satiety and only marginal weight loss because they are not appetite suppressants.25 Although controversial, disconnecting nutritive sweeteners from free-living diets may not address passive overeating. Worse yet, low-income populations are more affected because high-energy foods and beverages cost less than low-energy consumables.26 Put another way, most of us probably cannot win for losing.

Although a proverbial stretch from current studies in rats, more attention to potassium stores27 and uric acid levels28 may hypothetically help patients with metabolic syndrome, particularly if they are taking thiazide diuretics for control of hypertension. Only further human study will tell, but the sweetener epidemic is here. There is paradoxic subtext to the meaning of sugar-free, and with apologies to Pogo, the enemy is us.


    Disclosures
 Top
 Introduction
 Disclosures
 References
 
None.


    Footnotes
 
Published online ahead of print. Publication date available at www.jasn.org.

See the related article, "Thiazide Diuretics Exacerbate Fructose-Induced Metabolic Syndrome," on pages 2724–2731.


    References
 Top
 Introduction
 Disclosures
 References
 

  1. Bray GA, Nielsen SJ, Popkin BM: Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79 : 537 –543, 2004[Abstract/Free Full Text]
  2. Hallfrisch J: Metabolic effects of dietary fructose. FASEB J 4 : 2652 –2660, 1990[Abstract]
  3. Nakagawa T, Tuttle KR, Short RA, Johnson RJ: Hypothesis: Fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1 : 80 –86, 2005[CrossRef][Medline]
  4. Corn Refiners Association: A brief history of the corn refining industry, Washington, DC, Corn Refiners Association, 2002. Available at: http://www.corn.org/web/history.htm. Accessed August 18, 2007.
  5. Hanover LM, White JS: Manufacturing, composition, and applications of fructose. Am J Clin Nutr 58[Suppl] : 724S –732S, 1993[Medline]
  6. Putnam JJ: US food supply providing more food and calories. Food Rev 22 : 2 –12, 1999
  7. Putnam JJ, Allshouse JE: Food Consumption, Prices, and Expenditures, 1970–1997. Bulletin #965. Washington, DC, US Department of Agriculture Economic Research Service, 1999
  8. Huttunen JK: Fructose in medicine. A review with particular reference to diabetes mellitus. Postgrad Med J 47 : 654 –659, 1971[Abstract/Free Full Text]
  9. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25 : 202 –212, 2002[Free Full Text]
  10. Satcher D: The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity, Washington, DC, Government Printing Office, Department of Health and Human Services, Public Health Service, 2001
  11. Pollan M: You are what you grow, New York Times, 2007 . Available at: http://www.nytimes.com/2007/04/22/magazine/22wwlnlede.t.html?pagewanted=1&ei=5087%0A&em&en=5e517d47af28a63d&ex=1177905600
  12. Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D’Alessio D, Havel PJ: Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89 : 2963 –2972, 2004[Abstract/Free Full Text]
  13. Heinig M, Johnson RJ: Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73 : 1059 –1064, 2006[Abstract/Free Full Text]
  14. Zammit VA, Waterman IJ, Topping D, McKay G: Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131 : 2074 –2077, 2001[Abstract/Free Full Text]
  15. Kanabrocki EL, Third JL, Ryan MD, Nemchausky BA, Shirazi P, Scheving LE, McCormick JB, Hermida RC, Bremner WF, Hoppensteadt DA, Fareed J, Olwin JH: Circadian relationship of serum uric acid and nitric oxide. JAMA 283 : 2240 –2241, 2000[Free Full Text]
  16. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94 : 2511 –2515, 1994[Medline]
  17. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M: Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292 : F423 –F429, 2007[Abstract/Free Full Text]
  18. Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, Nakagawa T: Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol 18 : 2724 –2731, 2007[Abstract/Free Full Text]
  19. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP: LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315 : 1278 –1282, 2007[Abstract/Free Full Text]
  20. Rapoport MI, Hurd HF: Thiazide-induced glucose intolerance treated with potassium. Arch Intern Med 113 : 405 –408, 1964[Abstract/Free Full Text]
  21. Chazan JA, Boshell BR: Etiological factors in thiazide-induced or aggravated diabetes mellitus. Diabetes 14 : 132 –136, 1965[Medline]
  22. Ayvazian JH, Ayvazian LF: A study of the hyperuricemia induced by hydrochlorothiazide and acetazolamide separately and in combination. J Clin Invest 40 : 1961 –1966, 1961[Medline]
  23. Schiffman SS, Booth BJ, Losee ML, Pecore SD, Warwick ZS: Bitterness of sweeteners as a function of concentration. Brain Res Bull 36 : 505 –513, 1995[CrossRef][Medline]
  24. Schoenhals K: How sweet it is: Functional sweeteners. Natural Products Insider 2003 . Available at: www.naturalproductsinside.com/articles/331FunctionalFood.html. Accessed August 18, 2007
  25. Bellisle F, Drewnowski A: Intense sweeteners, energy intake and the control of body weight. Eur J Clin Nutr 61 : 691 –700, 2007[CrossRef][Medline]
  26. Drewnowski A, Darmon N: The economics of obesity: Dietary energy density and energy cost. Am J Clin Nutr 82 : 265S –273S, 2005[Abstract/Free Full Text]
  27. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL: Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension 48 : 219 –224, 2006[Abstract/Free Full Text]
  28. Choi HK, Ford ES: Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120 : 442 –447, 2007[CrossRef][Medline]

Related Article

Thiazide Diuretics Exacerbate Fructose-Induced Metabolic Syndrome
Sirirat Reungjui, Carlos A. Roncal, Wei Mu, Titte R. Srinivas, Dhavee Sirivongs, Richard J. Johnson, and Takahiko Nakagawa
J. Am. Soc. Nephrol. 2007 18: 2724-2731. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. E. Choi
The Not-so-Sweet Side of Fructose
J. Am. Soc. Nephrol., March 1, 2009; 20(3): 457 - 459.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007070750v1
18/10/2619    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neilson, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neilson, E. G.
Related Collections
Right arrowRelated Article


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP